Table 3 Troponin, creatinine, NT-proBNP levels
From: Myocardial protection with phosphocreatine in high-risk cardiac surgery patients: a randomized trial
Placebo (n = 63) | Phosphocreatine (n = 57) | p-value | |
|---|---|---|---|
Troponin I, pg/ml | |||
Baseline | 7.9 (4.7–17.7) | 4.95 (3.2–9.0) | 0.18 |
ICU admission | 10,890 (7,282–18,993) | 10,508 (6,838–18,045) | |
POD 1 | 8,609 (5,460–13,634) | 6,794 (4,227–10,103) | |
POD 2 | 5,318 (3,200–8,156) | 4,255 (3,165–6,416) | |
POD 3 | 2,505 (1,675–4,640) | 2,553 (1,624–3,716) | |
Peak postoperative troponin, pg/ml | 11,328 (7,660–22,894) | 10,508 (6,838–19,034) | 0.24 |
NT-proBNP pg/ml | |||
Baseline | 45.2 (8–89.1) | 18.5 (5.2–79) | 0.86 |
ICU admission | 47.2 (13.5–103.7) | 37.4 (19.2–76.8) | |
POD 1 | 67.8 (28.3–137) | 56.8 (29.9–101) | |
POD 2 | 104.5 (51.6–157) | 61.1 (39.2–126) | |
Peak post operative NT-proBNP, pg/ml | 104.5 (40.7–186,5) | 73.5 (38.3–164.5) | 0.36 |
Creatinine, µmol/L | |||
Baseline | 92 (79–102) | 87 (79–96) | 0.057 |
POD 1 | 95 (82–112) | 90 (80–100) | |
POD 2 | 90.5 (75–100) | 84 (68–99) | |
Peak postoperative serum creatinine, µmol/L | 99.5 (90–117) | 100 (85–117) | 0.87 |